Camrelizumab combined with platinum-free single-agent chemotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a prospective, single-arm, exploratory study

Cancer Treatment and Research Communications · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles